Background: Parkinson's disease (PD) is a neurodegenerative disease with an often complex component identifiable by genome-wide association studies. The most recent large-scale PD genome-wide association studies have identified more than 90 independent risk variants for PD risk and progression across more than 80 genomic regions. One major challenge in current genomics is the identification of the causal gene(s) and variant(s) at each genome-wide association study locus. The objective of the current study was to create a tool that would display data for relevant PD risk loci and provide guidance with the prioritization of causal genes and potential mechanisms at each locus. Methods: We included all significant genome-wide signals from multi...
A previous genome-wide association (GWA) meta-analysis of 12,386 PD cases and 21,026 controls conduc...
A previous genome-wide association (GWA) meta-analysis of 12,386 PD cases and 21,026 controls conduc...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Parkinson's disease (PD) is a neurodegenerative disease with an often complex component identifiable...
BackgroundParkinson's disease (PD) is a neurodegenerative disease with an often complex component id...
Background: Parkinson's disease (PD) is a neurodegenerative disease with an often complex component ...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
Parkinson’s disease (PD) is a severe neurodegenerative disease, resulting from complex interactions ...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
Although the causes of Parkinson's disease (PD) are thought to be primarily environmental, recent st...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
<div><p>More than 800 published genetic association studies have implicated dozens of potential risk...
Common variant genome-wide association studies (GWASs) have, to date, identified >24 risk loci for P...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
A previous genome-wide association (GWA) meta-analysis of 12,386 PD cases and 21,026 controls conduc...
A previous genome-wide association (GWA) meta-analysis of 12,386 PD cases and 21,026 controls conduc...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Parkinson's disease (PD) is a neurodegenerative disease with an often complex component identifiable...
BackgroundParkinson's disease (PD) is a neurodegenerative disease with an often complex component id...
Background: Parkinson's disease (PD) is a neurodegenerative disease with an often complex component ...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
Parkinson’s disease (PD) is a severe neurodegenerative disease, resulting from complex interactions ...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
Although the causes of Parkinson's disease (PD) are thought to be primarily environmental, recent st...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
<div><p>More than 800 published genetic association studies have implicated dozens of potential risk...
Common variant genome-wide association studies (GWASs) have, to date, identified >24 risk loci for P...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
A previous genome-wide association (GWA) meta-analysis of 12,386 PD cases and 21,026 controls conduc...
A previous genome-wide association (GWA) meta-analysis of 12,386 PD cases and 21,026 controls conduc...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...